z-logo
open-access-imgOpen Access
Antipsychotics in the treatment of neuropsychiatric symptoms in dementia
Author(s) -
Christopher J. Thomas
Publication year - 2012
Publication title -
mental health clinician
Language(s) - English
Resource type - Journals
ISSN - 2168-9709
DOI - 10.9740/mhc.n107156
Subject(s) - neuropsychopharmacology , psychiatry , dementia , medicine , antipsychotic , population , russian federation , geriatric psychiatry , schizophrenia (object oriented programming) , intensive care medicine , disease , environmental health , business , economic policy
The use of antipsychotics in the treatment of neuropsychiatric symptoms (NPS) in the geropsychiatric population is a controversial topic. Clinicians must be aware of current guidelines and best practices regarding antipsychotic use in long term care populations due to an associated risk of mortality. This article discusses and compares the guidelines regarding treatment of NPS published by the American College of Neuropsychopharmacology and the World Federation of Societies of Biological Psychiatry, and reviews the guidelines regarding gradual dose reduction in this population.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom